{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:54:57Z","timestamp":1761486897031,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1023\/a:1017215720949","type":"journal-article","created":{"date-parts":[[2002,12,29]],"date-time":"2002-12-29T20:25:02Z","timestamp":1041193502000},"page":"306-316","source":"Crossref","is-referenced-by-count":9,"title":["Mycobacterium tuberculosis-Secreted Protein Antigens: Immunogenicity in Baboons"],"prefix":"10.1007","volume":"20","author":[{"given":"Karen","family":"Pehler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"223930_CR1","first-page":"149","volume":"70","author":"P Sudre","year":"1992","unstructured":"Sudre P, ten Dam G, Kochi A: Tuberculosis: A global overview of the situation today. Bull World Health Organ 70:149-159, 1992","journal-title":"Bull World Health Organ"},{"key":"223930_CR2","first-page":"213","volume":"72","author":"PJ Dolin","year":"1994","unstructured":"Dolin PJ, Raviglione MC, Kochi A: Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 72: 213-220, 1994","journal-title":"Bull World Health Organ"},{"key":"223930_CR3","first-page":"1","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: Development of new vaccines for tuberculosis: Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Morbid Mortal Wkly Rep 47:1-6, 1998","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"223930_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0041-3879(76)90015-5","volume":"57","author":"K Styblo","year":"1976","unstructured":"Styblo K, Meiger J: Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle 57:17-43, 1976","journal-title":"Tubercle"},{"key":"223930_CR5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0035-9203(90)90172-B","volume":"84","author":"LC Rodriguez","year":"1990","unstructured":"Rodriguez LC, Smith PG: Tuberculosis in developing countries and methods for its control. Trans R Soc Trop Med Hyg 84:739-744, 1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"223930_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0962-8479(97)90022-8","volume":"78","author":"GG Jacobs","year":"1997","unstructured":"Jacobs GG, Johnson JL, Boom WH, Wallis RS, Whalen CC, Ginsberg AM: Tuberculosis vaccines: How close to human testing? Tuberc Lung Dis 78:159-169, 1997","journal-title":"Tuberc Lung Dis"},{"key":"223930_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/icb.1997.94","volume":"75","author":"MJ Elhay","year":"1997","unstructured":"Elhay MJ, Andersen P: Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol 75:595-603, 1997","journal-title":"Immunol Cell Biol"},{"key":"223930_CR8","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/iai.65.11.4515-4524.1997","volume":"65","author":"MG Sonnenberg","year":"1997","unstructured":"Sonnenberg MG, Belisle JT: Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing and electrospray mass spectrometry. Infect Immun 65:4515-4524, 1997","journal-title":"Infect Immun"},{"key":"223930_CR9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","volume":"92","author":"MA Horwitz","year":"1995","unstructured":"Horwitz MA, Lee B-Y, Dillon BJ, Harth G: Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 92:1530-1534, 1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"223930_CR10","first-page":"502","volume":"85","author":"AD Roberts","year":"1995","unstructured":"Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, Orme IM: Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502-508, 1995","journal-title":"Immunology"},{"key":"223930_CR11","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","volume":"62","author":"P Andersen","year":"1997","unstructured":"Andersen P: Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62:2536-2544, 1997","journal-title":"Infect Immun"},{"key":"223930_CR12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","volume":"2","author":"RE Tascon","year":"1996","unstructured":"Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB: Vaccination against tuberculosis by DNA injection. Nat Med 2:888-892, 1996","journal-title":"Nat Med"},{"key":"223930_CR13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","volume":"2","author":"K Huygen","year":"1996","unstructured":"Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, De Witt CM, Orme IM, Drowart A, Lozes E, Vandenbussche P, Van Vooren JP, Liu MA, Ulmer JB: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2:893-898, 1996","journal-title":"Nat Med"},{"key":"223930_CR14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","volume":"67","author":"AT Kamath","year":"1999","unstructured":"Kamath AT, Feng CG, MacDonald M, Briscoe H, Britton WJ: Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67:1702-1707, 1999","journal-title":"Infect Immun"},{"key":"223930_CR15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1086\/514132","volume":"176","author":"JJ Ellner","year":"1997","unstructured":"Ellner JJ: Review: The immune response in human tuberculosis\u2014Implications for tuberculosis control. J Infect Dis 176:1351-1359, 1997","journal-title":"J Infect Dis"},{"key":"223930_CR16","first-page":"19","volume-title":"Vaccines. From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use","author":"AB Onderdonk","year":"1999","unstructured":"Onderdonk AB, Kennedy RC: Use of animals for vaccine development. In Vaccines. From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use, LC Paoletti, PM McInnes (eds). New York, CRC Press LLC, 1999, pp 19-42"},{"key":"223930_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1574-695X.1997.tb01014.x","volume":"17","author":"R Attanasio","year":"1997","unstructured":"Attanasio R, Pehler K, Scinicariello F: DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes. FEMS Immunol Med Microbiol 17:207-215, 1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"223930_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/IAI.66.1.169-175.1998","volume":"66","author":"VLD Bonato","year":"1998","unstructured":"Bonato VLD, Lima VMF, Tascon RE, Lowrie DB, Silva CL: Identification and characterization of protective T cells in hsp65 DNA vaccinated and Mycobacterium tuberculosis infected mice. Infect Immun 66:169-175, 1998","journal-title":"Infect Immun"},{"key":"223930_CR19","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","volume":"280","author":"F Altare","year":"1998","unstructured":"Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435, 1998","journal-title":"Science"},{"key":"223930_CR20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CMR.11.3.514","volume":"11","author":"A Glatman-Freedman","year":"1998","unstructured":"Glatman-Freedman A, Casadevall A: Serum therapy for tuberculosis revisited: Reappraisal of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 11:514-532, 1998","journal-title":"Clin Microbiol Rev"},{"key":"223930_CR21","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","volume":"95","author":"R Teitelbaum","year":"1998","unstructured":"Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unanue E, Casadevall A, Bloom BR: A MAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 95:15688-15693, 1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"223930_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","volume":"400","author":"DB Lowrie","year":"1999","unstructured":"Lowrie DB, Tascon RE, Bonato VLD, Lima VMF, Faccioli LH, Stavropoulos E, Colston MJ, Hewinson RG, Moelling K, Silva CL: Therapy of tuberculosis in mice by DNA vaccination. Nature 400:269-271, 1999","journal-title":"Nature"},{"key":"223930_CR23","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","volume":"66","author":"SL Baldwin","year":"1998","unstructured":"Baldwin SL, D'Souza C, Roberts AD, Kelly BP, Frank AA, Lui MA, Ulmer JB, Huygen K, McMurray DM, Orme IM: Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 66:2951-2959, 1998","journal-title":"Infect Immun"},{"key":"223930_CR24","first-page":"197","volume-title":"The Comparative Pathology of Zoo Animals","author":"HM McClure","year":"1980","unstructured":"McClure HM: Bacterial diseases of nonhuman primates. In The Comparative Pathology of Zoo Animals, RJ Montali, G Migaki (eds). Washington DC, Smithsonian Institution Press, 1980, pp 197-204"},{"key":"223930_CR25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkeley CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. J Am Med Assoc 271:698-702, 1994","journal-title":"J Am Med Assoc"},{"key":"223930_CR26","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","volume":"284","author":"MA Behr","year":"1999","unstructured":"Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM: Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284, 1520-1523, 1999","journal-title":"Science"},{"key":"223930_CR27","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PEM Fine","year":"1995","unstructured":"Fine PEM: Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 346:1339-1345, 1995","journal-title":"Lancet"},{"key":"223930_CR28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-3083.1997.d01-99.x","volume":"46","author":"E Lozes","year":"1997","unstructured":"Lozes E, Denis O, Drowart A, Jurion F, Palfliet K, Vanonckelen A, De Bruyn J, De Cock M, Van Vooren JP, Huygen K: Crossreactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-group. Scand J Immunol 46:16-26, 1997","journal-title":"Scand J Immunol"},{"key":"223930_CR29","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0264-410X(98)00124-8","volume":"16","author":"PEM Fine","year":"1998","unstructured":"Fine PEM, Vynnycky E: The effect of heterologous immunity upon the apparent efficacy (e.g. BCG) vaccines. Vaccine 16:1923-1927, 1998","journal-title":"Vaccine"},{"key":"223930_CR30","first-page":"1","volume":"21","author":"JM Grange","year":"1984","unstructured":"Grange JM: The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness. Adv Tuberc Res 21:1-78, 1984","journal-title":"Adv Tuberc Res"},{"key":"223930_CR31","first-page":"662","volume":"135","author":"T Daniel","year":"1987","unstructured":"Daniel T, Debanne S: The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis 135:662-665, 1987","journal-title":"Am Rev Respir Dis"},{"key":"223930_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/cdli.4.1.49-56.1997","volume":"4","author":"S Laal","year":"1996","unstructured":"Laal S, Samanich KM, Sonnemberg MG, Zolla-Pazner S, Phadtare JM, Belisle J: Human humoral responses to antigens of Mycobacterium tuberculosis: Immunodominance of high molecular weight antigens. Clin Diag Lab Immunol 4:49-56, 1996","journal-title":"Clin Diag Lab Immunol"},{"key":"223930_CR33","first-page":"3036","volume":"66","author":"K Lyashchenko","year":"1998","unstructured":"Lyashchenko K, Colangeli R, Houde M, Jahdali HA, Menzies D, Gennaro ML: Heterogenous antibody responses in tuberculosis. Infect Immun 66:3036-3940, 1998","journal-title":"Infect Immun"},{"key":"223930_CR34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/icb.1997.94","volume":"75","author":"MJ Elhay","year":"1997","unstructured":"Elhay MJ, Andersen P: Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol 75:595-603, 1997","journal-title":"Immunol Cell Biol"},{"key":"223930_CR35","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","volume":"66","author":"CA Power","year":"1998","unstructured":"Power CA, Wei G, Bretscher PA: Mycobacterial dose defines the TH1\/TH2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun 66:5743-5750, 1998","journal-title":"Infect Immun"},{"key":"223930_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","volume":"15","author":"GW Comstock","year":"1994","unstructured":"Comstock GW: Field trials of tuberculosis vaccines: How could we have done them better? Control Clin Trials 15:247-276, 1994","journal-title":"Control Clin Trials"},{"key":"223930_CR37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/iai.52.1.293-302.1986","volume":"52","author":"M Harboe","year":"1986","unstructured":"Harboe M, Nagai S, Patarroyo ME, Tons ML, Ramirez C, Cruz N: Properties of proteins MBP64, MBP70, and MBP80 of Mycobacterium bovis BCG. Infect Immun 52:293-302, 1986","journal-title":"Infect Immun"},{"key":"223930_CR38","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/IAI.66.8.3606-3610.1998","volume":"66","author":"K Lyashchenko","year":"1998","unstructured":"Lyashchenko K, Manca C, Colangeli R, Heijbel A, Williams A, Gennaro ML: Use of Mycobacterium tuberculosis complexspecific antigen cocktails for a skin test specific for tuberculosis. Infect Immun 66:3606-3610, 1998","journal-title":"Infect Immun"},{"key":"223930_CR39","first-page":"1335","volume-title":"Fundamental Immunology","author":"SHE Kaufmann","year":"1998","unstructured":"Kaufmann SHE: Immunity to intracellular bacteria. In Fundamental Immunology, WE Paul (ed). Philadelphia, Lippincott-Raven Publishers, 1998, pp 1335-1371"},{"key":"223930_CR40","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1084\/jem.178.6.2243","volume":"178","author":"AM Cooper","year":"1993","unstructured":"Cooper AM, Dalton DK, Stewart TA, Griffin DG, Russell DG, Orme IM: Disseminated tuberculosis in IFN-\u03b3 gene-disrupted mice. J Exp Med 178:2242-2248, 1993","journal-title":"J Exp Med"},{"key":"223930_CR41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1086\/314707","volume":"179","author":"M Kimura","year":"1999","unstructured":"Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NMH, Chaisson RE, Bishai WR: Comparison between a whole blood interferon-\u03b3 release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis 179:1297-1300, 1999","journal-title":"J Infect Dis"},{"key":"223930_CR42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm\/148.2.378","volume":"148","author":"A Verbon","year":"1993","unstructured":"Verbon A, Weverling GJ, Kuijper S, Speelman P, Jansen L, Kolk AHJ: Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology. Am Rev Respir Dis 148:378-384, 1993","journal-title":"Am Rev Respir Dis"},{"key":"223930_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1054\/tuld.1998.0205","volume":"79","author":"MS Al-Hajjaj","year":"1999","unstructured":"Al-Hajjaj MS, Gad-El-Rab MO, Al-Orainey IO, Al-Kassimi FA: Improved sensitivity for detection of tuberculosis cases by a modified Anda-TB ELISA test. Tuber Lung Dis 79:181-185, 1999","journal-title":"Tuber Lung Dis"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017215720949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1017215720949\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017215720949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T13:41:09Z","timestamp":1751031669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1017215720949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["223930"],"URL":"https:\/\/doi.org\/10.1023\/a:1017215720949","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}